Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine

被引:0
|
作者
Alemayehu, Demissie [1 ]
Cappelleri, Joseph C. [1 ]
机构
[1] Pfizer Inc, Specialty Care Biostatist, New York, NY 10003 USA
来源
AMERICAN HEALTH AND DRUG BENEFITS | 2012年 / 5卷 / 05期
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Patient-reported outcomes (PROs) can play an important role in personalized medicine. PROs can be viewed as an important fundamental tool to measure the extent of disease and the effect of treatment at the individual level, because they reflect the self-reported health state of the patient directly. However, their effective integration in personalized medicine requires addressing certain conceptual and methodological challenges, including instrument development and analytical issues. Objectives: To evaluate methodological issues, such as multiple comparisons, missing data, and modeling approaches, associated with the analysis of data related to PRO and personalized medicine to further our understanding on the role of PRO data in personalized medicine. Discussion: There is a growing recognition of the role of PROs in medical research, but their potential use in customizing healthcare is not widely appreciated. Emerging insights into the genetic basis of PROs could potentially lead to new pathways that may improve patient care. Knowledge of the biologic pathways through which the various genetic predispositions propel people toward negative or away from positive health experiences may ultimately transform healthcare. Understanding and addressing the conceptual and methodological issues in PROs and personalized medicine are expected to enhance the emerging area of personalized medicine and to improve patient care. This article addresses relevant concerns that need to be considered for effective integration of PROs in personalized medicine, with particular reference to conceptual and analytical issues that routinely arise with personalized medicine and PRO data. Some of these issues, including multiplicity problems, handling of missing values and modeling approaches, are common to both areas. It is hoped that this article will help to stimulate further research to advance our understanding of the role of PRO data in personalized medicine. Conclusion: A robust conceptual framework to incorporate PROs into personalized medicine can provide fertile opportunity to bring these two areas even closer and to enhance the way a specific treatment is attuned and delivered to address patient care and patient needs.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 50 条
  • [31] 'The patient': at the center of patient-reported outcomes
    Awad, A. George
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (05) : 729 - 731
  • [32] App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE)
    Doerner, Lorenz
    Grosse, Lucia
    Stange, Felix
    Hille, Hanni
    Kurz, Sylvia
    Becker, Hannes
    Volkmer, Sebastian
    Hippler, Melina
    Rieger, David
    Bombach, Paula
    Rieger, Johannes
    Weinert, Lina
    Svensson, Laura
    Anders, Carolin
    Cekin, Sila
    Paulsen, Frank
    Oener, Oeznur
    Ruhm, Kristina
    Malek, Holly Sundberg
    Moeller, Yonne
    Tatagiba, Marcos
    Wallwiener, Markus
    Eckert, Nils
    Escher, Pascal
    Pfeifer, Nico
    Forschner, Andrea
    Bauer, Armin
    Zips, Daniel
    Bitzer, Michael
    Malek, Nisar
    Gani, Cihan
    Tabatabai, Ghazaleh
    Renovanz, Mirjam
    [J]. NEURO-ONCOLOGY PRACTICE, 2024, 11 (03) : 336 - 346
  • [33] Considerations to Support Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures in Ambulatory Clinics
    Cox, Elizabeth D.
    Dobrozsi, Sarah K.
    Forrest, Christopher B.
    Gerhardt, Wendy E.
    Kliems, Harald
    Reeve, Bryce B.
    Rothrock, Nan E.
    Lai, Jin-Shei
    Svenson, Jacob M.
    Thompson, Lindsay A.
    Tran, Thuy Dan N.
    Tucker, Carole A.
    [J]. JOURNAL OF PEDIATRICS, 2021, 230 : 198 - +
  • [34] Interpretation of patient-reported outcomes
    Cappelleri, Joseph C.
    Bushmakin, Andrew G.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2014, 23 (05) : 460 - 483
  • [35] Patient-reported outcomes in schizophrenia
    McCabe, Rosemarie
    Saidi, Marya
    Priebe, Stefan
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : S21 - S28
  • [36] PATIENT-REPORTED OUTCOMES: AN INTRODUCTION
    Apfelbacher, Christian
    Nelson, Pauline
    [J]. ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1023 - 1024
  • [37] Patient-reported outcomes in endocrinology
    De Sanso, S.
    Guidi, J.
    Fava, G. A.
    Sonino, N.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 19 - 19
  • [38] Patient-Reported Outcomes in Dermatology
    Kirby, Joslyn S.
    [J]. JAMA DERMATOLOGY, 2022, 158 (01) : 97 - 98
  • [39] Patient-Reported Outcomes in Orthopaedics
    Christensen, Daniel L.
    Dickens, Jonathan F.
    Freedman, Brett
    Mauntel, Timothy
    Owens, Brett D.
    Potter, Benjamin K.
    Provencher, Matthew
    Tokish, John M.
    Waterman, Brian R.
    Antosh, Ivan
    Bellamy, Jaime
    Cameron, Kenneth L.
    Cook, Karon F.
    Eckel, Tobin T.
    Eichinger, Josef K.
    Garcia, EStephan J.
    Helgeson, Melvin D.
    Joyner, Patrick W.
    Kang, Daniel G.
    Kilcoyne, Kelly G.
    Krueger, Chad A.
    LeClere, Lance E.
    Li, Xinning
    Martin, Kevin D.
    McCallum, Jeremy R.
    McDonald, Lucas S.
    Ortiz, Dionisio, III
    Pallis, Mark P.
    Parada, Stephen A.
    Patzkowski, Jeanne C.
    Posner, Matthew A.
    Rivera, Jessica C.
    Robins, R. Judd
    Rothrock, Nan
    Schmitz, Matthew R.
    Slabaugh, Mark
    Song, Daniel J.
    Stinner, Daniel J.
    Tintle, Scott M.
    Tucker, Christopher J.
    Waltz, Robert A.
    Wilson, Kevin
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2018, 100 (05): : 436 - 442
  • [40] Patient-Reported Outcomes Matter
    Gellad, Walid F.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (05): : 296 - 297